APLT Applied Therapeutics Inc
Price (delayed)
$5.21
Market cap
$598.35M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.45
Enterprise value
$476.37M
Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate,
Highlights
The quick ratio has surged by 195% year-on-year and by 26% since the previous quarter
APLT's debt has dropped by 67% year-on-year and by 37% since the previous quarter
The company's net income has shrunk by 120% YoY but it rose by 17% QoQ
APLT's revenue has dropped by 103% year-on-year but it is up by 30% since the previous quarter
Key stats
What are the main financial stats of APLT
Market
Valuations
Earnings
Shares outstanding
114.85M
Market cap
$598.35M
Enterprise value
$476.37M
Price to earnings (P/E)
N/A
Price to book (P/B)
8.22
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
-$333,000
EBIT
-$161.09M
EBITDA
-$160.72M
Free cash flow
-$73.24M
Per share
Balance sheet
Liquidity
EPS
-$1.45
Free cash flow per share
-$0.51
Book value per share
$0.63
Revenue per share
$0
TBVPS
$0.89
Total assets
$127.78M
Total liabilities
$55.39M
Debt
$215,000
Equity
$72.39M
Working capital
$72.22M
Debt to equity
0
Current ratio
2.3
Quick ratio
2.21
Net debt/EBITDA
0.76
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-170%
Return on equity
-577.9%
Return on invested capital
N/A
Return on capital employed
-222.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
APLT stock price
How has the Applied Therapeutics stock price performed over time
Intraday
0.19%
1 week
-8.6%
1 month
-16.1%
1 year
206.47%
YTD
55.52%
QTD
11.56%
Financial performance
How have Applied Therapeutics's revenue and profit performed over time
Revenue
-$333,000
Gross profit
-$333,000
Operating income
-$78.04M
Net income
-$161.09M
Gross margin
N/A
Net margin
N/A
The company's net income has shrunk by 120% YoY but it rose by 17% QoQ
APLT's revenue has dropped by 103% year-on-year but it is up by 30% since the previous quarter
The company's gross profit has shrunk by 103% YoY but it rose by 30% QoQ
Applied Therapeutics's operating income has decreased by 18% YoY and by 4.4% from the previous quarter
Growth
What is Applied Therapeutics's growth rate over time
Valuation
What is Applied Therapeutics stock price valuation
P/E
N/A
P/B
8.22
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 31% YoY but it rose by 21% QoQ
APLT's price to book (P/B) is 42% more than its 5-year quarterly average of 5.8
The equity has grown by 8% since the previous quarter
APLT's revenue has dropped by 103% year-on-year but it is up by 30% since the previous quarter
Efficiency
How efficient is Applied Therapeutics business performance
The return on equity has surged by 90% year-on-year and by 74% since the previous quarter
The return on assets has increased by 35% since the previous quarter and by 2.1% year-on-year
Dividends
What is APLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for APLT.
Financial health
How did Applied Therapeutics financials performed over time
The company's total assets is 131% higher than its total liabilities
The quick ratio has surged by 195% year-on-year and by 26% since the previous quarter
The company's total assets has surged by 193% YoY but it fell by 16% QoQ
APLT's debt is 100% smaller than its equity
The company's debt to equity has shrunk by 100% QoQ but it has surged by 100% YoY
APLT's debt has dropped by 67% year-on-year and by 37% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.